Personalized medicine is significantly changing the fundamentals of healthcare. Genetic diagnostic tests are used in various parts of medicine from initial screening to the diagnosis and finallytreatment. Investigations in fields of drug development indicate that oncology may lead other therapeutic areas in the number of targeted therapies on the marketplace as well as in the pipeline, expecting that within a few years, all oncology medications will have a related diagnosis. It has been shown that personal genomics will influence other important therapeutic areas, including the clinical decision making. In conclusion, personalized medicine is just getting started for hematology and respiratory medical therapies, as well as oncology.
Ghayoor Karimiani, E. (2013). Personalized Cancer Medicine: a Future Direction of Personal Genomics. Razavi International Journal of Medicine, 1(1), 3-4. doi: 10.30483/rijm.2013.254526.1326
MLA
Ghayoor Karimiani, E. . "Personalized Cancer Medicine: a Future Direction of Personal Genomics", Razavi International Journal of Medicine, 1, 1, 2013, 3-4. doi: 10.30483/rijm.2013.254526.1326
HARVARD
Ghayoor Karimiani, E. (2013). 'Personalized Cancer Medicine: a Future Direction of Personal Genomics', Razavi International Journal of Medicine, 1(1), pp. 3-4. doi: 10.30483/rijm.2013.254526.1326
CHICAGO
E. Ghayoor Karimiani, "Personalized Cancer Medicine: a Future Direction of Personal Genomics," Razavi International Journal of Medicine, 1 1 (2013): 3-4, doi: 10.30483/rijm.2013.254526.1326
VANCOUVER
Ghayoor Karimiani, E. Personalized Cancer Medicine: a Future Direction of Personal Genomics. Razavi International Journal of Medicine, 2013; 1(1): 3-4. doi: 10.30483/rijm.2013.254526.1326